Long-Term Multicenter Evaluation of the E1® Tibial Bearing
Status unconfirmed · Not applicable
Conditions studied: Osteoarthritis of the Knee, Traumatic Arthritis of the Knee
In brief
This study has been designed to document the long-term outcome of the E1® Tibial Bearings used with the Vanguard® Knee System in 500 patients receiving total knee arthroplasty. All patients will receive the E1® Tibial Bearing in a Vanguard® knee replacement. Radiographic analysis and patient reported outcomes will be used as follow-up measures to track wear, mechanical performance, and patient satisfaction.
Key facts
- Study ID
- NCT01374230
- Run by
- Massachusetts General Hospital
- People needed
- 500
- Starts
- 2011-09-01
- Expected to finish
- 2021-09-01
- Last updated by the study team
- 2018-07-30
Who can join
Age: 20 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or Female
- 20 to 75 years of age
- Subjects requiring total knee replacement
- Subjects with the diagnosis of osteoarthritis, or traumatic arthritis
- Subjects who demonstrate the ability to return to Massachusetts General Hospital for follow-up for the next 10 years
You may not qualify if…
- Subjects with osteoporosis, osteomalacia, or neuromuscular disease
- Incomplete or insufficient soft tissue around the knee
- Subjects with a limited life span
- Subjects who have difficulty comprehending the study protocol for any reason
- Subjects with disorders which may impair bone formation
- Subjects whose bony structure deviates substantially from the general norm
- Female subjects that are, or may become, pregnant while participating in this study
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.